Epitope Diagnostics is proud to announce that a new set of monoclonal antibodies specific to auristatins is now commercially available. The novel clones are specific against detecting monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), two anti-cancer compounds. Using these new monoclonal antibodies, we were able to successfully develop highly sensitive MMAE-ADC and MMAF-ADC ELISA kits.
These monoclonal antibodies are very stable at 2-8°C and come in a PBS buffer. The isotype of both antibodies is IgG1.
We have confirmed that it is possible for these antibodies to be coated on a solid phase, as well as having the capability to be used as a detection antibodies. Biotinylation and HRP-conjugation is also a possibility; these are available upon request.
